TNF Pharmaceuticals, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
TNF Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • TNF Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -187 %, a 102% decline year-over-year.
  • TNF Pharmaceuticals, Inc. annual Return On Equity for 2023 was -30.9 %, a 65% increase from 2022.
  • TNF Pharmaceuticals, Inc. annual Return On Equity for 2022 was -88.4 %, a 46.6% increase from 2021.
  • TNF Pharmaceuticals, Inc. annual Return On Equity for 2021 was -165 %, a 166% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -30.9 +57.5 +65% Jan 1, 2023 Dec 31, 2023
2022 -88.4 +77 +46.6% Jan 1, 2022 Dec 31, 2022
2021 -165 -415 -166% Jan 1, 2021 Dec 31, 2021
2020 250 +397 Jan 1, 2020 Dec 31, 2020
2019 -147 -26.2 -21.6% Jan 1, 2019 Dec 31, 2019
2018 -121 +12.2 +9.16% Jan 1, 2018 Dec 31, 2018
2017 -134 -56.2 -72.7% Jan 1, 2017 Dec 31, 2017
2016 -77.3 +9.84 +11.3% Jan 1, 2016 Dec 31, 2016
2015 -87.2 -67.5 -342% Jan 1, 2015 Dec 31, 2015
2014 -19.7 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.